Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.16%
0%
-8.16%
6 Months
-6.16%
0%
-6.16%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Specialized Medical Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.00%
EBIT Growth (5y)
50.76%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
4.84
EV to EBIT
22.29
EV to EBITDA
16.28
EV to Capital Employed
3.59
EV to Sales
3.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.10%
ROE (Latest)
18.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
382.70
380.00
0.71%
Operating Profit (PBDIT) excl Other Income
97.60
71.70
36.12%
Interest
12.40
13.00
-4.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
66.20
36.40
81.87%
Operating Profit Margin (Excl OI)
193.10%
127.80%
6.53%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.71% vs 3.01% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 81.87% vs 22.97% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,439.60
1,367.90
5.24%
Operating Profit (PBDIT) excl Other Income
324.60
302.30
7.38%
Interest
45.00
48.50
-7.22%
Exceptional Items
0.00
0.00
Consolidate Net Profit
185.20
168.70
9.78%
Operating Profit Margin (Excl OI)
164.70%
156.90%
0.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 5.24% vs 13.17% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 9.78% vs 63.79% in Dec 2023






